Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

Rates of fatal drug overdoses are higher than expected in most states, despite a 14.5% decrease in the year leading up to June 2024.

Some monotherapies have significant differences in efficacy for vitiligo, whereas other modalities have similar efficacy between therapies.

RFK Jr ordered the shutdown of a page claiming to be the CDC promoting false information suggesting that vaccines may cause autism.

Alpha-gal syndrome, a severe and life-threatening allergy to red meat, has been linked to tick bites in Maine and Washington.

Alopecia areata incidence was highest in patients in North America, Southeast Asia, and Australia, as well as in women and those aged 30 to 34 years.

A memo suggests that the government may end the CDC’s HIV Prevention Division, which tracks infections and promotes prevention.

The FDA has launched an online searchable database with information for consumers about chemical contaminants in foods.

Universal opt-out programs raise sexually transmitted infection screening rates in adolescents, though confidentiality issues may affect commercially insured patients.

A retrospective cohort study revealed that nicotinamide exposure among adults did not increase the risk for major adverse cardiovascular events.

Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.

The total age-adjusted injury death rate among Americans was higher in 2023 than in 2013, reaching a peak in 2021.